Shanghai, China

Shuzhang Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuzhang Zhang. Retrieved from https://idiyas.com/inventor/shuzhang-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shuzhang Zhang: Innovator in Antiepileptic Research

Introduction

Shuzhang Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical science, particularly in the development of antiepileptic treatments. His innovative work has the potential to improve the lives of many individuals suffering from epilepsy.

Latest Patents

Shuzhang Zhang holds a patent for the "Antiepileptic toxin Martentoxin and use thereof." This patent describes the anti-epileptic toxin Martentoxin (MarTX), its derivatives, and their applications. Specifically, it details the use of Martentoxin or an active fragment thereof, or a pharmaceutically acceptable salt thereof, in preparing a composition for treating and/or preventing epilepsy. This groundbreaking research confirms for the first time that Martentoxin can effectively treat and/or prevent epileptic symptoms.

Career Highlights

Zhang is affiliated with the Chinese Academy of Sciences, where he conducts his research. His work has garnered attention for its innovative approach to treating epilepsy, showcasing his dedication to advancing medical science.

Collaborations

Some of his notable coworkers include Yonghua Ji and Xinlian Liu, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Shuzhang Zhang's contributions to the field of antiepileptic research highlight his role as an influential inventor. His patent on Martentoxin represents a significant advancement in the treatment of epilepsy, showcasing the potential for innovative solutions in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…